-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Targeted protein degradation is a hot area of new drug development.
Autophagy is a way for cells to break down cytoplasmic components such as unwanted or harmful proteins and organelles
Previous studies have found that a receptor called p62 plays a key role in mediating targeted autophagy
▲The mechanism of action of AUTOphagy-TArgeting Chimera (AUTOTAC) (Image source: Reference [1])
Based on this concept, the researchers developed a variety of small-molecule compounds capable of activating p62 and tested their ability to degrade soluble proteins in vitro
In addition, the researchers examined the effect of the AUTOTAC technology on degrading aggregates composed of misfolded proteins
In this study, the scientists designed an AUTOTAC molecule that binds to a tau protein mutant, tauP301L, that readily forms neurofibrillary tangles
Previously, researchers have developed targeted protein degraders (called AUTACs) that stimulate autophagy by inducing specific ubiquitin modifications on the protein surface
References:
[1] Ji et al.